Authors: JABER LA HALAPY H FERNET M TUMMALAPALLI S DIWAKARAN H

Citation: La. Jaber et al., EVALUATION OF A PHARMACEUTICAL CARE MODEL ON DIABETES MANAGEMENT, The Annals of pharmacotherapy, 30(3), 1996, pp. 238-243

Authors: MAKI A DIWAKARAN H REDMAN B ALASFAR S PETTIT GR MOHAMMAD RM ALKATIB A

Citation: A. Maki et al., THE BCL-2 AND P53 ONCOPROTEINS CAN BE MODULATED BY BRYOSTATIN-1 AND DOLASTATINS IN HUMAN DIFFUSE LARGE-CELL LYMPHOMA, Anti-cancer drugs, 6(3), 1995, pp. 392-397

Authors: MOHAMMAD RM DIWAKARAN H MAKI A EMARA MA PETTIT GR REDMAN B ALKATIB A

Citation: Rm. Mohammad et al., BRYOSTATIN 1 INDUCES APOPTOSIS AND AUGMENTS INHIBITORY EFFECTS OF VINCRISTINE IN HUMAN DIFFUSE LARGE-CELL LYMPHOMA, Leukemia research, 19(9), 1995, pp. 667-673

Authors: MOHAMMAD R MAKI A DIWAKARAN H PETTIT R ALKATIB A

Citation: R. Mohammad et al., BRYOSTATIN-1 INDUCES APOPTOSIS AND AUGMENTS INHIBITORY EFFECTS OF VINCRISTINE IN HUMAN DIFFUSE LARGE-CELL LYMPHOMA, Blood, 84(10), 1994, pp. 10000448-10000448